Alterations of the p53 tumor suppressor gene are the most common genet
ic changes found so far in breast cancer, suggesting that the gene pla
ys a central role in the development of the disease. p53 functions as
a negative regulator of cell growth, and alterations in the gene lead
to loss of this negative growth regulation and more rapid cell prolife
ration. A number of independent groups using different methods of dete
ction have shown that p53 alterations are associated with more aggress
ive tumor biologic factors and a poorer prognosis in breast cancer pat
ients. Because of its possible role in the regulation of apoptosis and
response to DNA damage, p53 status could also be a predictive marker
for response to hormonal or chemotherapy